Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: RETRACTED ARTICLE: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

Fig. 5

Effect of DFX on Rac1 activation in pancreatic cancer cells. Pancreatic cancer cells were treated with DFX (0, 10, 50, or 100 μM); after 48 h of incubation, Rac1 activation was measured using G-LISA in (a) BxPC-3 cells(n = 3), b Panc-1 cells (n = 3), and (c) HPAF II cells (n = 3). Data are presented as mean ± SD. *P < 0.05, **P < 0.01

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us